The journal of cardiovascular computed tomography: A year in review: 2022
- PMID: 36934047
 - DOI: 10.1016/j.jcct.2023.03.001
 
The journal of cardiovascular computed tomography: A year in review: 2022
Abstract
This review aims to summarize key articles published in the Journal of Cardiovascular Computed Tomography (JCCT) in 2022, focusing on those that had the most scientific and educational impact. The JCCT continues to expand; the number of submissions, published manuscripts, cited articles, article downloads, social media presence, and impact factor continues to grow. The articles selected by the Editorial Board of the JCCT in this review highlight the role of cardiovascular computed tomography (CCT) to detect subclinical atherosclerosis, assess the functional relevance of stenoses, and plan invasive coronary and valve procedures. A section is dedicated to CCT in infants and other patients with congenital heart disease, in women, and to the importance of training in CT. In addition, we highlight key consensus documents and guidelines published in JCCT last year. The Journal values the tremendous work by authors, reviewers, and editors to accomplish these contributions.
Keywords: CTA=coronary CT angiography; HRP=high risk plaques; TAVR=Transcatheter aortic valve replacement.
Copyright © 2023. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest Gianluca Pontone: No conflict of interest. Saima Mushtaq: No conflict of interests. Subhi J Al'Aref: Supported by NIH 2R01 HL12766105 & 1R21 EB030654 and receives royalty fees from Elsevier. Daniele Andreini: No conflict of interest. Andrea Baggiano: No conflict of interest. Arzu Canan: Royalties from Elsevier. Joao L. Cavalcante: Consultant - 4C, Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, JenaValve, Medtronic, VDyne, WL Gore, Xylocor. Research Grant: Abbott Structural, Boston Scientific, Edwards Lifesciences, Abbott Northwestern Hospital Foundation. Anjali Chelliah: No conflict of interest. Marcus Chen: No conflict of interest. Andrew Choi: Conflicts: Consultant – Siemens Healthineers; Equity – Cleerly, Inc. Grant Support: GW Heart and Vascular Institute. Dey Damini: No conflict of interest. Carlo Nicola De Cecco: received institutional research support and/or personal speaker/consulting fees from Bayer and Siemens. Kanwal M. Farooqi: No conflict of interest. Maros Ferencik: Conflicts: Consulting fees – HeartFlow, Elucid, Siemens Healthineers, Grants – AHA, NIH. Gudrun Feuchtner: No conflict of interest. Harvey Hecht: part of the Arineta Scientific Advisory Board. Heidi Gransar: No conflict of interest. Márton Kolossváry: No conflict of interest. Jonathon Leipsic: Consultant and Stock options Heartflow; Consultant Circle CVI and Arineta; Speakers bureau GE Healthcare. MichaelT.Lu: Has received funding to his institution from AstraZeneca, MedImmune, and Kowa. Mohamed Marwan: Honoraria/Consulting Edwards Lifescience, Siemens Healthineers. Ming-Yen Ng: Funding from TeraRecon, GE, Circle Cardiovascular Imaging, Arterys. Pál Maurovich-Horvat: No conflict of interest. Prashant Nagpal: No conflict of interest. Ed Nicol: Advisory Board, Caristo Diagnostics. Jonathan Weir-McCall: is supported by the NIHR Cambridge Biomedical Research Center (BRC-1215-20,014). Seamus P. Whelton: No conflict of interest. Michelle C Williams: Speaker bureau for Canon Medical Systems, Siemens Healthineers and Novartis. Anna Reid: No conflict of interest. Timothy A. Fairbairn: No conflict of interest. Todd Villines: Salary support from Elucid, Bioimaging, Inc. Rosemarie Vliegenthart: No conflict of interest. Armin Arbab-Zadeh: Research grant, Canon Medical Systems.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
